Nortriptyline Colonis

Nortriptyline, the active ingredient in Nortriptyline Colonis, is a tricyclic antidepressant presented as a strength/form for oral use. It treats major depressive disorder, neuropathic pain and chronic tension-type headache in adults.

GNH USA supplies Nortriptyline Colonis as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nortriptyline acts on mood regulation and pain pathways, making it useful for several neurological and psychiatric conditions. - Major depressive disorder: alleviates depressive symptoms by improving mood and energy levels. - Neuropathic pain: reduces pain intensity associated with peripheral nerve injury. - Chronic tension-type headache: decreases frequency and severity of tension-type headache episodes.

Common Side Effects: - Dry mouth: reduced salivary flow causing discomfort. - Constipation: slowed gastrointestinal motility. - Drowsiness: increased sedation, especially at treatment initiation. - Weight gain: increased appetite leading to modest weight increase. Serious or Rare Side Effects: - Cardiac arrhythmia: potential conduction abnormalities, especially in patients with pre‑existing heart disease. - Seizures: lowered seizure threshold, risk in susceptible individuals. - Severe hypotension: marked drop in blood pressure upon standing.

Precautions should be taken to minimize risks and ensure safe use. - Cardiovascular assessment: evaluate heart rhythm and conduction before initiating therapy. - Seizure risk: avoid in patients with a history of seizures unless benefits outweigh risks. - Drug interactions: review concomitant medications that affect CYP2D6 or cardiac conduction. - Elderly monitoring: start with low dose and monitor for anticholinergic effects. - Pregnancy and lactation: discuss potential risks with prescriber; use only if clearly needed. - Store at ambient temperature: keep below 25°C in original packaging, protect from moisture and light.

Nortriptyline may interact with several drug classes, requiring careful management. Major Interactions (Avoid): - MAO inhibitors: concurrent use can cause hypertensive crisis or serotonin syndrome. - CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): may increase nortriptyline plasma levels, raising toxicity risk. - QT‑prolonging agents (e.g., quinidine, sotalol): additive risk of cardiac arrhythmias. Moderate Interactions (Monitor Closely): - Anticholinergic agents (e.g., diphenhydramine): may enhance anticholinergic side effects. - CNS depressants (e.g., alcohol, benzodiazepines): can increase sedation and impair coordination. - Diuretics: may potentiate orthostatic hypotension.